The rise in antimicrobial resistance is an increasingly critical public health issue worldwide. It requires the mobilisation of various public and private players in the healthcare sector. Among them, pharmaceutical companies such as Pfizer have been involved for years in the fight again ...
While the need for new antibiotics is urgent and should naturally attract investors, there is too little innovation and R&D in the field of antibiotic resistance. We are facing what is known as a market failure, the main reason for which is linked to the need to preserve their value for publ ...
The emergence and development of antibiotic resistance is mainly linked to the inappropriate use of antibiotics. In vitro diagnostic systems and tests detect and identify pathogens and assess their sensitivity to certain antibiotics, that is why they have a key role in ...